Open Label, Randomized Multicenter Study Docetaxel + 5-Fluorouracil + Cisplatin Compared to Cisplatin + 5-Fluorouracil in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer
- Focus Registrational; Therapeutic Use
- 02 Oct 2012 Results presented at the 37th Congress of the European Society for Medical Oncology.
- 30 Sep 2012 Primary endpoint 'Progression-free-survival-duration' has been met.
- 30 Aug 2012 Actual end date added as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History